Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD3 antibody are fused to the C terminus of an anti-DLL3 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget T cells to tumor cells. It is designed for the research of Lung cancer; Pancreatic cancer; Skin cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD3 x Human Anti-DLL3 Bispecific Antibody (IgG(L)-scFv) (IGLFV-H252). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS